Encision Inc. completed a $500,000 private placement of common stock with private investors.
The funds secured will support operations and prepare for the expected launch of the new ENT Device in early 2026.
The private placement included 5 million common shares at a per share price of $0.10.
Funding Secured
The $500,000 private placement provides necessary funds for operations and product development.
New Device Launch
Preparation for the launch of the new ENT Device in early 2026 is a key focus for Encision Inc.
Investor Group
The private placement involved the Company's directors, executive officers, existing shareholders, and new investors.
- Encision Inc. can now proceed with development and sales efforts for the new ENT Device.
- The additional funding enhances the company's ability to advance its portfolio of surgical instrumentation with AEM technology.
Encision Inc.'s successful completion of the private placement sets a positive trajectory for future growth and product innovation.